Skip to ContentSkip to Navigation
How to find us dr. R.H. Enting

Research interests


Neurological infections



Radiation dose-dependent long-term neurocognitive decline in low grade glioma patients:results of a cross-sectional study

The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review

Limited external reproducibility restricts the use of medical record review for benchmarking

Perfusion MRI in treatment evaluation of glioblastomas: Clinical relevance of current and future techniques

Quantifying effects of radiotherapy-induced microvascular injury; review of established and emerging brain MRI techniques

Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial

Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study

The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: A phase 3, randomised, open-label intergroup study

Treatment of initial parenchymal central nervous system involvement in systemic aggressive B-cell lymphoma

Read more